Mahfouz R, El-Rewini H, Ghoneim SI, Sheta A, Ali EA, Ibrahim M
Mendona MM, da Cruz KR, Pinheiro DDS
Some women with PCOS report improved menstrual regularity on GLP-1 therapy, likely due to weight loss and improved insulin sensitivity rather than direct effects on the ovaries
This makes it a potential candidate for research into cognitive decline and brain health
Patients must maintain documentation showing the prescription was issued for a diagnosed conditiontypically type 2 diabetes, prediabetes, or documented obesity with comorbidities like hypertension or sleep apnea
If you're already taking a GLP-1 medication (or considering one) and would like more guidance on how to align your nutrition, we're hosting a masterclass on this topic